Respiratory technology company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to announce that it has been advised by Sigma Healthcare (ASX:SIG) that Mute sleep technology will form part of the 2017 core range for the Amcal and Guardian pharmacy brands.
Sigma Healthcare Ltd
Sigma Healthcare Limited (ASX:SIG), formerly Sigma Pharmaceuticals Limited, is engaged in pharmacy wholesale and distribution business. The Company operates over 1,200 branded and independent stores, including pharmacy retail brands, such as Amcal, Guardian, PharmaSave, Chemist King and Discount Drug Stores. It has partnership agreements to provide independent pharmacy support services to more than 500 independent pharmacies. Its Sigma Financial Services provide support services to help pharmacies better manage their finances; offers pharmacy finance referral program, and pharmacy fit-out finance with tailored bank support.
The Company also operates online store to offer approximately 9,000 products to consumers. It also operates Sigma Generics Program (SGP) to drive generic substitution and pharmacist profitability. It also operates Sigma Resource Centre to provide customizable levels of support to suit the needs of all pharmacies, branded or independent.
Rhinomed (ASX:RNO) is pleased to announce it has continued to expand its Australian wholesale pharmacy distribution footprint with Sigma Pharmaceuticals Limited (ASX:SIP) to wholesale its Mute™ snoring and sleep quality technology.
Australian market fell on Wednesday led by financial and energy stocks with low trading volume during the session. The gains in US and Europe markets in previous session fail to inspired investors as they feared more disappointing US economic data could come out.
Australian Market Report of May 31, 2010: Avita Medical (ASX:AVH) Advances Marketing in China and Taiwan
The Australian shares opened slightly lower this morning with weak overseas lead. Fitch Ratings has downgraded Spain's credit rating from AAA to AA-plus, saying the country's economic recovery will be more muted than the government forecast. The local market is under pressure after the downgrade fuelled concerns over the Eurozone crisis.
Australian Market Report of May 21, 2010: GUD Holdings (ASX:GUD) to Make Takeover Bid for Dexion (ASX:DEX)
The Australian share market sank massively at opening on Friday, after Wall Street and European markets overnight slumped again due to Europe debt jitters. The Dow Jones industrial average experienced its deepest one-day plunge in more than a year, as investors feared that the European debt crisis might spread around the world.
Wall Street closed flat yesterday after the market rallied for two days. Traders turned cautious before the third quarter earnings kick off. Alcoa (NYSE:AA), the first company to unveil its earnings, posted a better-than-expected result with third quarter net income of US$77 million, after three consecutive quarters of losses.
Wall Street closed in negative territory on Friday despite a survey showed that US consumer sentiment rose to its strongest level in three months. But the Dow still surged 164 points, or 1.74 per cent, with four days rally in the week.
US markets were closed for the Labour Day public holiday, while Europe and Asia markets posted strong gains on Monday.
Wall Street was higher on Friday as a government report showed that the pace of job losses slowed in August. But the US stocks were still in negative territory for the week with the worst performance since early July.
The Australian share market closed marginally lower as financial stocks plunged. The benchmark S&P/ASX200 fell 14 points, or 0.4 per cent, to close at 3465.8, while the broader All Ordinaries was down 11.4 points, or 0.33 per cent, to 3405.0. Analysts said it will be difficult for the market to rally as the previous two weeks. The rise in the period took the S&P/ASX200 index up by more than 10%.